Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology

Sci Rep. 2020 Jan 30;10(1):1845. doi: 10.1038/s41598-020-57846-6.

¹ Rigenerand srl, Medolla, Modena, Italy. olivia.candini@rigenerand.it.
² Rigenerand srl, Medolla, Modena, Italy.
³ Division of Chest Surgery, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
⁴ Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
⁵ Technopole of Mirandola, Mirandola, Modena, Italy.
⁶ Medical Oncology 2, Veneto Institute of Oncology IOV, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy.
⁷ Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
⁸ Rigenerand srl, Medolla, Modena, Italy. massimo.dominici@unimore.it.
⁹ Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy. massimo.dominici@unimore.it.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.